• Room 03.028 - Whitla Medical Building

    United Kingdom

Accepting PhD Students

PhD projects

I am always open to PhD applications in the field of nanopharmaceutical, targeted delivery, smart and novel nanomaterials, exosomes, immunotherapy, tumour microenvironment, and nanotoxicology.


Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Statement

Dr Al-Jamal is an overseas (Jordan) and a UK-registered pharmacist. She completed her PhD in Nanotechnology and Drug Delivery from London School of Pharmacy (now known as UCL School of Pharmacy), following receiving the prestigious Overseas Research Scholarship (ORS) Award from the University of London. Her PhD research project focused on developing novel liposome-based systems for combinatory therapeutic and diagnostic purposes. In 2008, Dr Al-Jamal joined UCL School of Pharmacy as a Research Fellow focusing on live animal imaging and evaluating organ biodistribution of a variety of novel gene and drug delivery vectors. In 2012, she was appointed at The Institute of Pharmaceutical Science, King’s College London as a Senior Research Associate, focusing on evaluating the behaviour and the efficacy of personalised nanomedicines to treat cancer. Dr Al-Jamal joined the University of East Anglia, Norwich, as a Lecturer in Nanomedicine and Drug Delivery (2013-2014), before being awarded a five-year Career Development Fellowship from Prostate Cancer UK, to develop novel nanomedicines targeting metastatic prostate cancer. In August 2017, Dr Al-Jamal joined Queen’s University Belfast School of Pharmacy as a Reader in Nanomedicine and Drug Delivery.

Dr Al-Jamal is a Visiting Professor at Guizhou Medical School, Guiyang, China. She was the GSK Emerging Scientist Award winner for 2015 for her work in the field of Cancer Nanomedicine. She also received the prestigious international Gro Brundtland Award, Taiwan, that recognizes distinguished female scientists in the field of sustainable development.



Research Interests

Dr Al-Jamal's multidisciplinary team works on developing novel nanomedicines for combinatory therapy and theranostic applications. Currently, her research focuses on developing smart vectors for delivering a broad range of therapeutic agents, and to fabricate multifunctional nanoparticles to target cancer and other diseases. Her long-term research career is to facilitate the translation of nanoparticle-based therapeutics from the lab to the clinic.

Fingerprint Dive into the research topics where Wafa Al-Jamal is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Liposome-Templated Indocyanine Green J- Aggregates for In Vivo Near Infrared Imaging and Stable Photothermal Heating

Cheung, C. C. L., Ma, G., Karatasos, K., Seitsonen, J., Ruokolainen, J., Koffi, C-R., Hassan, H. & Al-Jamal, W. T., 28 Feb 2020, In : Nanotheranostics. 4, 2, p. 91-106 16 p.

Research output: Contribution to journalArticle

Open Access
  • 9 Downloads (Pure)
  • Organ Biodistribution of Radiolabelled γδ T Cells Following Liposomal Alendronate Administration in Different Mouse Tumour Models

    Wang, J. T-W., Hodgins, N. O., Al-Jamal, W., Maher, J., Sosabowski, J. K. & Al-Jamal, K. T., 06 Feb 2020, In : Nanotheranostics. 4, 2, p. 71-82 12 p.

    Research output: Contribution to journalArticle

    Open Access
  • 13 Downloads (Pure)

    Exploiting Current Understanding of Hypoxia Mediated Tumour Progression for Nanotherapeutic Development

    Feng, J., Byrne, N. M., Al Jamal, W. & Coulter, J. A., 11 Dec 2019, In : Cancers. 11, 12, 25 p., 1989.

    Research output: Contribution to journalReview article

    Open Access
  • 14 Downloads (Pure)

    Intracellular Activation of a Prostate Specific Antigen-Cleavable Doxorubicin Prodrug: A Key Feature Toward Prodrug-Nanomedicine Design

    Pereira, S. G. T., Hudoklin, S., Kreft, M. E., Kostevsek, N., Stuart, M. C. A. & Al-Jamal, W. T., 25 Feb 2019, In : Molecular Pharmaceutics.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Citation (Scopus)
    15 Downloads (Pure)


    Gro Brundtland Award for Women in Sustainable Development, Taiwan

    Wafa Al-Jamal (Recipient), 16 Mar 2017

    Prize: National/international honour

    GSK Emerging Scientist Award (£1000), UK

    Wafa Al-Jamal (Recipient), 07 Sep 2015

    Prize: Prize (including medals and awards)

    Novel Targeted Nanomedicine for Metastatic Prostate Cancer

    Wafa Al-Jamal (Recipient), 31 Mar 2014

    Prize: Fellowship awarded competitively

  • Activities

    • 12 Invited or keynote talk at national or international conference
    • 7 Invited talk
    • 1 Participation in conference

    41st All Ireland Schools of Pharmacy conference

    Wenrui Zhang (Participant), Wafa Al-Jamal (Participant), Thakur Raghu Raj Singh (Participant)
    17 Apr 201918 Apr 2019

    Activity: Participating in or organising an event typesParticipation in conference

    Photothermally Activated Magnetoliposomes for Cancer Therapy and Imaging

    Wafa Al-Jamal (Invited speaker)
    02 Sep 201805 Sep 2018

    Activity: Talk or presentation typesInvited or keynote talk at national or international conference

    Temperature-Sensitive Magnetoliposomes for Photothermally Triggered Drug Release & MR Imaging

    Wafa Al-Jamal (Invited speaker)
    26 Sep 201829 Sep 2018

    Activity: Talk or presentation typesInvited or keynote talk at national or international conference

    Nanotechnology for Cancer Immunotherapy and Cell Programming

    Wafa Al-Jamal (Invited speaker)
    25 Jun 2018

    Activity: Talk or presentation typesInvited talk

    Nanoparticle Drug Delivery in Cancer

    Wafa Al-Jamal (Keynote speaker)
    26 Jun 201829 Jun 2018

    Activity: Talk or presentation typesInvited or keynote talk at national or international conference